An Early Examination of Access to Select Orphan Drugs Treating Rare Diseases in Health Insurance Exchange Plans

BACKGROUND: Patients with rare diseases often face significant health care access challenges, particularly since the number of available treatment options for rare diseases is limited. The implementation of health insurance exchanges promises improved access to health care. However, when purchasing...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, Sandy W., Brantley, Kelly, Liow, Christine, Teagarden, J. Russell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2014
Materias:
Contemporary Subject
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441028/
https://www.ncbi.nlm.nih.gov/pubmed/25278322
http://dx.doi.org/10.18553/jmcp.2014.20.10.997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441028/
https://www.ncbi.nlm.nih.gov/pubmed/25278322
http://dx.doi.org/10.18553/jmcp.2014.20.10.997

Ejemplares similares